You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B-cell lymphoproliferative disorder

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accuracy Evaluation of the IdentiClone Dx IGH Assay

Not yet recruiting
  • B-Cell Lymphoproliferative Disorder
  • IdentiClone Dx IGH (IC IGH Dx) Assay
  • San Diego, California
  • +2 more
Oct 30, 2023

Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

Active, not recruiting
  • Post-transplant Lymphoproliferative Disorder
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 16, 2023

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

Not yet recruiting
  • Post-Transplant Lymphoproliferative Disorder
  • +10 more
  • Loncastuximab Tesirine
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2022

Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

Not yet recruiting
  • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
  • Polymorphic Post-Transplant Lymphoproliferative Disorder
  • Biopsy
  • +5 more
  • New Brunswick, New Jersey
  • +2 more
Mar 23, 2023

Lymphoma Trial in Stanford (rituximab)

Completed
  • Lymphoma
  • rituximab
  • Stanford, California
    Stanford University Medical Center
May 25, 2022

Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

Recruiting
  • Epstein-Barr Virus Infections
  • +2 more
  • Group A
  • Group B
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Apr 5, 2022

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

Not yet recruiting
  • Lymphoproliferative Disorders
  • +3 more
  • No intervention
  • (no location specified)
Jan 30, 2023

Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

Active, not recruiting
Has Results
  • Follicular Lymphoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 6, 2022

Severe COVID-19 Infection in CLL or B-NHL Who Received

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
    • (no location specified)
    Apr 6, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Primary Immune Regulatory Disorder, Autoimmune Lymphoproliferative, Immune System Diseases Trial in United States (Emapalumab,

    Recruiting
    • Primary Immune Regulatory Disorder
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 15, 2023

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

    Not yet recruiting
    • Allogeneic Stem Cell Transplant Candidate
    • +4 more
    • Cellular therapy product
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 1, 2022

    Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

    Not yet recruiting
    • Lymphoma, Mantle-Cell
    • +7 more
    • (no location specified)
    Jun 21, 2022

    LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

    Recruiting
    • LGLL - Large Granular Lymphocytic Leukemia
    • +13 more
    • Duarte, California
    • +9 more
    Aug 9, 2022

    Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

    Recruiting
    • Immune Deficiency Disorders
    • +13 more
    • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
    • Saint Louis, Missouri
      Washington University
    Apr 25, 2022

    Family Study of Lymphoproliferative Disorders

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Aug 30, 2021

      Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

      Recruiting
      • Hodgkin's Disease
      • +3 more
      • EBV-specific T cells: A
      • EBV-specific T cells: B
      • Houston, Texas
      • +1 more
      Jun 28, 2022

      Clinical, Laboratory and Epidemiologic Characterization of

      Recruiting
      • Waldenstrom Macroglobulinemia
      • +4 more
        • Bethesda, Maryland
        • +1 more
        Jan 25, 2023

        Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

        Terminated
        Has Results
        • Adult Grade III Lymphomatoid Granulomatosis
        • +116 more
        • brentuximab vedotin
        • +2 more
        • Chicago, Illinois
        • +2 more
        Aug 30, 2021

        Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

        Completed
        Has Results
        • Adult Nasal Type Extranodal NK/T-cell Lymphoma
        • +18 more
        • Scottsdale, Arizona
        • +1 more
        Sep 28, 2020

        Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

        Recruiting
        • Brain and Central Nervous System Tumors
        • +8 more
        • 3'-deoxy-3'-[18F]fluorothymidine
        • Detroit, Michigan
          Barbara Ann Karmanos Cancer Institute
        Mar 30, 2022